Taxpayers could foot the bill for more than 30 types of gender reassignment surgery under an Australian Society of Plastic Surgeons application being considered by a federal government agency, which argues the procedures can be “life-saving”.
Public submissions to the Medical Services Advisory Committee regarding the application close on Friday, with MSAC expected to meet next month to discuss the matter.
Under the ASPS proposal, new Medicare item numbers would cover procedures on adults diagnosed with gender incongruence including hysterectomy and removal of ovaries, removal of testes and penis, mastectomy, breast enhancement, phalloplasty, construction of a “neovagina”, facial feminisation and reduction of the Adam’s apple.
The application has received support from groups including the Royal Australasian College of Surgeons and the federally funded LGBTIQ+ Health Australia, which has previously argued the surgeries are medically necessary and can have a “life-saving” impact on the mental health of a cohort with an elevated risk of suicide and self-harm.
However, other medical experts and groups, including Genspect Australia and the LGB Alliance, have expressed grave concern regarding a lack of long-term evidence for the safety and efficacy of the irreversible and often high-risk procedures being performed on vulnerable patients.
The 21-member MSAC is chaired by Adelaide-based pediatric nephrologist and epidemiologist Jonathan Craig, and predominantly made up of medical specialists with expertise in areas including health economics, public health and clinical medicine, in addition to two consumer members. It considers applications such as the one submitted by the ASPS, before making recommendations to the health minister.
The ASPS initially submitted an application in March 2023 that envisaged transgender surgeries for children, and proposed that patients could be referred to surgeons from general practitioners, with no requirement for psychiatric assessment, but has since been forced to narrow its focus.
The latest application is restricted to adult surgeries, with assessment by a “multidisciplinary team” required for referral, although exactly how this process will work is not yet clear.
It comes after the MSAC last year found the ASPS had failed to prepare a systematic review of the medical evidence to the required standard, and that the ASPS’s claim that the surgery had clinical effectiveness was “highly uncertain and not well supported”.
This followed a round of public consultation that generated 2706 submissions, 92.5 per cent of which supported taxpayer funding of surgeries.
‘Evidence lacking’
“The recommendation that the MSAC will make is immensely important, as vulnerable people seeking relief from distress may see Medicare listing as reassurance that the surgeries are safe, effective and appropriate for them,” said Dr Nadia David, chair of Genspect Australia, a health charity promoting a non-medicalised approach to sex and gender.
“People considering irreversible surgery deserve treatments that are based on reliable long-term evidence about benefits and harms. This is currently lacking.
“Genspect Australia is particularly concerned that the research literature under-reports adverse experiences and regret.
“Problems can take years to emerge, people who are doing poorly are less likely to respond to surveys, and acknowledging regret after such a momentous decision can be immensely difficult.”
One common cause of regret is poor surgical outcomes, with complications varying widely across the different surgeries, and genital surgeries the most challenging.
In its 2025 submission, the RACS provided some evidence of the relative complexity of the procedures, stating: “A plastic surgeon can perform 4–5 masculinisation mastectomies per day, whereas a free flap phalloplasty, done well, requires two surgeons and a full day.”
Two-stage phalloplasty involves creation of a mock penis from a flap of skin taken from the forearm, and challenging surgery to create a longer urethra is needed to fulfil a key goal for most patients – urination while standing.
A third stage can allow insertion of a pump in a newly constructed testicle to allow a hydraulic erection.
Complication rates for phalloplasty were acknowledged by the MSAC to be 31.5 per cent to 43.8 per cent, and there is a high rate of re-operation, due to either patient dissatisfaction, mechanical failure or infection.
In one notorious Belgian case, biologically female 44-year-old Nathan Verhelst, who underwent procedures including phalloplasty and mastectomy, was granted medical euthanasia in 2013 on the grounds of “unbearable psychological suffering” as a result of severe surgical complications and symptoms of anatomical rejection.
Vaginoplasty involves inversion of the skin of the penis to line a cavity that becomes the “neovagina”. However, for those who have been given puberty blockers this is generally not possible due to lack of penile tissue, and a section of bowel or peritoneum is used to make the neovaginal lining.
One patient treated under the “Dutch protocol” – the clinical framework that subsequently formed the basis for “gender-affirming care” around the world, including in Australia – died at 18 as a result of uncontrollable infection arising from use of a section of colon to form the “neovagina”.
An Australian doctor practising in urology who wished to remain anonymous told The Australian: “The literature shows that up to 29 per cent of vaginoplasty cases suffer complications and 10 per cent need re-operation.
“The complications of this surgery, many of which I have seen in the emergency department, include fistula (an opening between the neovagina and rectum or urethra), stenosis (narrowing or closing of the neovagina), urinary incontinence, necrosis of the relocated skin, rectal injury, abscess and repeated urinary tract infections. The removal of penis and testes results in permanent sterility, and is irreversible for detransitioners. In addition, the current literature is of poor quality, with usually only short follow-up.”
‘Risk of regret’
Karleen Gribble, an Australian public health researcher and Adjunct Professor at Western Sydney University, has published a case study of post-mastectomy regret in a formerly transgender-identified young woman.
“It is concerning that Australian guidelines for gender transition treatments do not include counselling regarding the impact of surgery on the ability to breastfeed,” Professor Gribble said.
“It seems extraordinary that discussion of the impact of the removal of an organ, as occurs with chest masculinisation surgery, would not be discussed.
“It is not unusual for adolescent girls and young women to hate their breasts, but there is not any long-term data to show that mastectomies give significant benefit. The risk of regret, in those who undertake surgery young, if they later become pregnant and give birth, is very real.”
‘Gay conversion 2.0’
Lesbian and gay group LGB Alliance Australia expressed concern that young same-sex-attracted individuals were being unduly influenced to believe they were transgender.
“Many of those identifying as transgender are same-sex-attracted, and LGB Alliance Australia is concerned that Medicare funding would further institutionalise what we call ‘gay conversion 2.0’,” spokeswoman Marce Hamilton said. “Public policy should support young people to accept themselves, not subsidise interventions that reinforce a belief that their body needs changing.
“For a young man to internally resolve that he is actually gay only after having had his penis removed is devastating, and many lesbians are also making permanent alterations to their bodies with long-term health consequences.”
Another LGB Alliance member, who spoke to The Australian on the condition of anonymity, said: “I came very close to having a double mastectomy during an incredibly troubled period of my life, yet at no point was I encouraged to seriously explore why I wanted such a major irreversible surgery. It was friends, not the system, who asked me to slow down.
“That space let me work through some tough stuff and eventually feel completely at home in my body. I’m profoundly grateful I paused. I believe people considering irreversible surgery deserve genuine curiosity and careful exploration of what may be driving their distress before they make a permanent decision.”
During several years of preparation for the current application, the ASPS collaborated with the Australian Professional Association for Transgender Health (AusPATH), transgender advocacy organisation ACON, and the University of Melbourne Trans Health Research Group.
The surgeries are proposed for adults diagnosed with “gender incongruence”, defined by the World Health Organisation as “a marked and persistent incongruence between an individual’s experienced gender and the assigned sex”, and contrasts with the diagnosis for gender dysphoria, which is considered a mental health issue and has associated distress.
Given the diagnosis of gender incongruence requires no underlying pathology, it is questionable whether the proposed surgeries meet the Health Insurance Act’s requirement that Medicare-funded services are clinically relevant, and unclear how they differ from elective cosmetic surgery.
If the application were to be approved as it stands, biological men would be eligible for cosmetic breast surgery but women would not, raising an interesting question of sex discrimination in medical treatment.
The original ASPS application asserted that transgender surgeries for those with gender incongruence would prevent possible later development of gender dysphoria or distress, and were thus analogous to prophylactic mastectomy to prevent breast cancer in women with cancer-related gene variants.
In its assessment of the application, the MSAC considered there was some confidence in results showing improvement in quality of life for patients followed for 6-12 months post-surgery.
However, longer-term outcomes remain largely unknown, with some data suggesting the early stages post-surgery can be an effective “honeymoon” period, with satisfaction declining thereafter. The MSAC noted that the reliability of published work was marred by high patient dropout from studies and the use of subjective measures of wellbeing.
One study of thousands of patients diagnosed initially with gender dysphoria but no other mental health disorders, published last year in the Journal of Sexual Medicine, relied on medical records rather than subjective patient self-reporting.
It found that those who underwent transgender surgeries were significantly more likely to develop depression, anxiety, substance abuse and suicidal ideation.
A 2011 study analysed outcomes for all post-operative transgender Swedes over periods of up to 30 years, and found a 19-fold increase in the rate of suicide compared with the general population, suggesting mental health problems may not be resolved longer-term post surgery.
The applicability of the existing research to the Australian cohort was questioned by the MSAC, as it largely relates to the historical population of middle-aged natal males seeking feminisation, whereas those identifying as transgender now are increasingly young natal females, with a large number identifying as non-binary.
In what appears to be an effort to provide the missing evidence in favour of gender-affirming surgery, South Australian plastic surgeon Dr Nicola Dean, the ASPS president at the time of the initial MSAC application, has formed a Gender Affirming Surgery Research Group affiliated with Flinders University and the Southern Adelaide Local Health Network.
This group aims to identify “how improved access to gender-affirming surgery may improve health” and produce evidence “to support Australian-specific health funding and policy decision-making”. In contrast, Genspect Australia promotes management of gender-related distress through conventional psychotherapeutic techniques.
“Overcoming feelings of gender incongruence requires not surgery, but the freeing of an individual from restrictive gender stereotypes – there is no right way to be a man or a woman,” said Genspect board director Dr Sandra Pertot, a retired clinical psychologist who specialised in gender and sexuality.
“Since the 1970s, I have supported feminist and gay rights campaigns promoting acceptance of gender nonconformity, and it disturbs me that modern gender theory seeks to re-establish old stereotypes.
“With gender dysphoria it is important that there is in-depth psychological assessment and management well before any decisions about permanent procedures.”
‘Care can be effective’
In response to detailed questions, an ASPS spokeswoman said that while the MSAC application was under way, surgeons were not available for interview.
The ASPS’s official position on what it refers to as “gender-affirming” surgery states: “Healthcare for people with gender incongruence is a complex area of medicine and people seeking surgery to affirm their gender deserve access to safe and appropriate care, delivered in privacy and with respect.
“Clinical research indicates that people with gender incongruence have a higher risk of distress and mental health issues than the general population, and that surgical care can be very effective in improving the mental health and quality of life of these individuals,” the ASPS states.
“The weight of published medical literature now clearly shows that there is strong evidence to support provision of gender-affirming surgery services.
“Not everyone with gender incongruence needs surgical care. But some do. ASPS supports the view that adults with these concerns are best managed in multidisciplinary services according to evidence-based principles and with a patient-centred approach.
“Representatives of our specialty are currently participating in an application to the government and medical authorities, alongside other relevant medical specialties, to allow for more streamlined and accessible care in this area.
“ASPS is not involved in developing services for children or adolescents with these conditions.
“It is important that pathways of care are patient-centred and based on the medical evidence.”
Consideration of the ASPS application comes as clinicians, detransitioners, parents, lawyers, academics and other advocates for a more cautious, evidence-based approach to gender medicine are set to convene at the Coalition Advancing Scientific Care conference in Adelaide on Friday and Saturday.
The keynote address will be delivered by Irish psychotherapist and global Genspect founder Stella O’Malley, with other headline presentations from University College London neuropsychology professor Sallie Baxendale, who has pioneered research warning of the potential for puberty blockers to adversely impact cognitive development, and Tavistock clinic whistleblowers, husband-and-wife psychotherapists Marcus and Sue Evans.
Lifeline: 13 11 14, lifeline.org.au
Beyond Blue: 1300 224 635, beyondblue.org.au
eDITORIAL P12